The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase I administration of YS110, a monoclonal antibody directed against the CD26 immunostimulatory molecule in advanced cancer patients.
 
ERIC ANGEVIN
No Relationships to Disclose
 
Nicolas Isambert
Consulting or Advisory Role - Merck Serono; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim; PharmaMar; Roche Pharma AG
 
Veronique N. Trillet-Lenoir
No Relationships to Disclose
 
Benoit You
No Relationships to Disclose
 
Jérôme Alexandre
Honoraria - Janssen; Merck; PharmaMar; Roche Pharma AG; Sanofi
Travel, Accommodations, Expenses - Janssen; PharmaMar; Roche Pharma AG
 
Gerard Zalcman
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Lilly (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche
 
Philippe Viehl
No Relationships to Disclose
 
Françoise Farace
Honoraria - Boehringer Ingelheim; Roche Pharma AG
Consulting or Advisory Role - Novartis
Research Funding - Pfizer (Inst)
 
Fanny Valleix
Employment - Elro Pharma; Immupharma
 
Thomas Podoll
Employment - Y's Therapeutics
Consulting or Advisory Role - Kissei Pharmaceutical
 
Yu Kuramochi
Employment - Kissei Pharmaceutical
 
Itaru Miyashita
Employment - Kissei Pharmaceutical
Stock and Other Ownership Interests - Kissei Pharmaceutical
 
Osamu Hosono
No Relationships to Disclose
 
Nam H. Dang
Stock and Other Ownership Interests - Y's Therapeutics
 
Kei Ohnuma
Stock and Other Ownership Interests - Y's Therapeutics
 
Taketo Yamada
Stock and Other Ownership Interests - Y's Therapeutics
Consulting or Advisory Role - Kissei Pharmaceutical
Research Funding - Y's Therapeutics
 
Yutaro Kaneko
Employment - Y's Therapeutics
Leadership - Y's Therapeutics
Stock and Other Ownership Interests - Y's Therapeutics
Research Funding - Y's Therapeutics
Patents, Royalties, Other Intellectual Property - Ajinomoto
Travel, Accommodations, Expenses - Y's Therapeutics
 
Chikao Morimoto
Stock and Other Ownership Interests - Y's Therapeutics
Consulting or Advisory Role - Kissei Pharmaceutical
Research Funding - Kissei Pharmaceutical
Patents, Royalties, Other Intellectual Property - Y's Therapeutics
Travel, Accommodations, Expenses - Kissei Pharmaceutical